An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
Clinical trial NCT00165880 · TERMINATED
Trial details
- NCT number
- NCT00165880
- Sponsor
- Eisai Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.